Newborn Screening Practitioner's Manual
COVER PAGE |
TABLE OF CONTENTS |
INTRODUCTION |
MEDICAL PROGRAM FOLLOW-UP AND CONSULTANTS |
SCREENING TESTS
- AMINO ACID DISORDERS (PKU, MSUD, HCY, TYR I, ASA & CIT)
- Introduction
- Amino Acid Disorders Screened in Kansas
- Clinical Features
- Laboratory Screening Tests
- Confirmatory Testing
- Treatment
- Screening Practice Considerations
- Medical Consultant
- Overview of Follow-up Procedure
- Amino Acid Disorder ACT Sheets
- Amino Acid Disorder Algorithms
- Low Risk Physician’s Letter Example
- Moderate Risk Physician’s Letter Example
- High Risk Physician’s Letter Example
- Physician’s Reporting Form Examples
- Information for Healthcare Providers
- Parent Letter Example
- Information for Parents
- BIOTINIDASE DEFICIENCY (BIOT)
- Introduction
- Clinical Features
- Causes of Biotinidase Deficiency
- Laboratory Screening Tests
- Confirmatory Testing
- Treatment
- Screening Practice Considerations
- Medical Consultant
- Overview of Follow-up Procedure
- ACT Sheet
- Algorithm
- Presumptive Physician’s Letter Example
- Physician’s Reporting Form Example
- Information for Healthcare Providers
- Parent Letter Example
- Information for Parents
- CONGENITAL ADRENAL HYPERPLASIA (CAH)
- Introduction
- Clinical Features
- Causes of Congenital Adrenal Hyperplasia
- Laboratory Screening Tests
- Confirmatory Testing
- Treatment
- Medical Consultants
- Overview of Follow-Up Procedure
- ACT Sheet
- Algorithm
- Borderline Physician’s Letter Example
- Presumptive Physician’s Letter Example
- Physician’s Reporting Form Example
- Information for Healthcare Providers
- Parent Letter Example
- Information for Parents
- CONGENITAL HYPOTHYROIDISM (CH or HYPOTH)
- Introduction
- Clinical Features
- Causes of Congenital Hypothyroidism
- Laboratory Screening Tests
- Confirmatory Testing
- Treatment
- Screening Practice Considerations
- Medical Consultants
- Overview of Follow-Up Procedure
- ACT Sheet
- Algorithm
- Borderline Physician’s Letter Example
- Presumptive Physician’s Letter Example
- Physician’s Reporting Form Example
- Information for Healthcare Providers
- Parent Letter Example
- Information for Parents
- CYSTIC FIBROSIS (CF)
- Introduction
- Clinical Features
- Causes of Cystic Fibrosis
- Laboratory Screening Tests
- Confirmatory Testing
- Treatment
- Screening Practice Considerations
- Medical Consultants
- Overview of Follow-Up Procedure
- ACT Sheet
- Algorithm
- Initial Positive Physician’s Letter Example
- Repeat Positive Physician’s Letter Example
- Physician’s Reporting Form Example
- Information for Healthcare Providers
- Parent Letter Example
- Information for Parents
- FATTY ACID OXIDATION DISORDERS (MCADD, VLCAD, LCHADD, TFP & CUD)
- Introduction
- Fatty Acid Oxidation Disorders Screened in Kansas
- Clinical Features
- Laboratory Screening Tests
- Confirmatory Testing
- Treatment
- Screening Practice Considerations
- Medical Consultant
- Overview of Follow-up Procedure
- Fatty Acid Oxidation Disorder ACT Sheets
- Fatty Acid Oxidation Disorder Algorithms
- Low Risk Physician’s Letter Example
- Moderate Risk Physician’s Letter Example
- High Risk Physician’s Letter Example
- Physician’s Reporting Form Examples
- Information for Healthcare Providers
- Parent Letter Example
- Information for Parents
- GALACTOSEMIA (GALT)
- Introduction
- Clinical Features
- Laboratory Screening Tests
- Confirmatory Testing
- Treatment
- Screening Practice Considerations
- Medical Consultants
- Overview of Follow-Up Procedure
- ACT Sheet
- Algorithm
- Borderline Physician’s Letter Example
- Presumptive Physician’s Letter Example
- Physician’s Reporting Form Example
- Information for Healthcare Providers
- Parent Letter Example
- Information for Parents
- HEMOGLOBINOPATHIES
- Introduction
- Clinical Features
- Laboratory Tests
- Confirmatory Testing
- Treatment
- Carrier Detection
- Screening Practice Considerations
- Infant Transfusion
- Medical Consultants
- Follow-Up Procedure
- Inheritance Patterns
- ACT Sheets
- Algorithm
- Physician's Letter Example - Hgb Traits
- Physician's Letter Example - Hgb Disease
- Physician's Reporting Form Example
- Information for Healthcare Providers
- Parent Letter Example - Hgb Traits
- Parent Letter Example - Hgb Disease
- Information for Parents
- ORGANIC ACID DISORDERS (IVA, GA-1, HMG, MCD, MUT, Cbl A&B, 3MCC, PROP & BKT)
- Introduction
- Clinical Features
- Causes of Organic Acid Disorders
- Laboratory Screening Tests
- Confirmatory Testing
- Treatment
- Screening Practice Considerations
- Medical Consultants
- Overview of Follow-up Procedure
- ACT Sheets
- Algorithms
- Low Risk Physician’s Letter Example
- Moderate Risk Physician’s Letter Example
- High Risk Physician’s Letter Example
- Physician’s Reporting Forms
- Information for Healthcare Providers
- Parent Letter Example
- Information for Parents
- PHENYLKETONURIA (PKU)
- Introduction
- Clinical Features
- Laboratory Tests
- Confirmatory Testing
- Treatment
- Screening Practice Considerations
- Variant Forms of PKU
- Maternal PKU and Hyperphenylalaninemia
- Medical Consultants
- Overview of Follow-Up Procedure
- Follow-Up Flow Chart
- ACT Sheet
- Algorithm
- Low Risk Physician’s Letter
- Moderate Risk Physician’s Letter
- High Risk Physician’s Letter
- Physician’s Reporting Form
- Information for Healthcare Providers
- Parent Letter
- Information for Parents
- SPECIAL HEALTH SERVICES
- Services Available – General Information
- Eligibility
- Services for Newborn Screening Disorders
- SCREENING PRACTICES
- Screening Kit Information
- Completion of the Form
- Sample Screening Kit
- Timing of Testing
- Obtaining the Specimen
- Mailing Instructions
- Reporting of Results
- Reporting and Follow-up of “Presumptive” Results
- Problems in Screening Practices
- Testing Before Discharge
- Protein and Lactose Ingestion Prior to Testing
- Testing Before Transfer of Infant to Another Unit
- Completion of the Form
- Transfusions
- Infants Who Are Never Tested
- Specimen Inadequacy
- Parent Refusal of Testing
|